Campbell Stewart

Campbell joined Novo Ventures in 2022 as a Senior Associate. Previous to that, Campbell was an Associate in the Healthcare Team at Rothschild and Co investment bank in London with a primary focus on Biotech transactions. Campbell has worked on a broad range of Biotech transactions including sell-side and buy-side M&A deals, licensing deals, royalty financings and strategic reviews.

Campbell holds a degree in Clinical Medicine (BMBCh) and a Masters degree in Medical Sciences with a focus on cardiovascular physiology, both from the University of Oxford.